Interaction of Remdesivir with Clinically Relevant Hepatic Drug Uptake Transporters

Remdesivir has been approved for treatment of COVID-19 and shortens the time to recovery in hospitalized patients. Drug transporters removing remdesivir from the circulation may reduce efficacy of treatment by lowering its plasma levels. Information on the interaction of remdesivir with drug transpo...

Descripción completa

Detalles Bibliográficos
Autores principales: Nies, Anne T., König, Jörg, Hofmann, Ute, Kölz, Charlotte, Fromm, Martin F., Schwab, Matthias
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2021
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7999182/
https://www.ncbi.nlm.nih.gov/pubmed/33802215
http://dx.doi.org/10.3390/pharmaceutics13030369

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7999182/
https://www.ncbi.nlm.nih.gov/pubmed/33802215
http://dx.doi.org/10.3390/pharmaceutics13030369

Ejemplares similares